The Department of Pharmacology & Therapeutics is proud to announce that Qingchen “Jeremy” Yuan, has been selected by the American Society of Hematology (ASH) to receive in the 2025 ASH Graduate Hematology Award, part of ASH’s investment hematology research and the next generation of hematology physicians and scientists.
Through this award, Jeremy will receive funding to conduct hematology research over a two-year period. Jeremy’s project will focus on myloid cancer.